0001104659-20-076965.txt : 20200625 0001104659-20-076965.hdr.sgml : 20200625 20200625191617 ACCESSION NUMBER: 0001104659-20-076965 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200625 FILED AS OF DATE: 20200625 DATE AS OF CHANGE: 20200625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Partners Innovation Fund II, L.P. CENTRAL INDEX KEY: 0001689717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39343 FILM NUMBER: 20990553 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-307-2400 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akouos, Inc. CENTRAL INDEX KEY: 0001722271 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-245-5715 MAIL ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 3 1 a3.xml 3 X0206 3 2020-06-25 0 0001722271 Akouos, Inc. AKUS 0001689717 Partners Innovation Fund II, L.P. 215 FIRST STREET, SUITE 500 CAMBRIDGE MA 02142 0 0 1 0 Series Seed Preferred Stock Common Stock 68501 D Series A Preferred Stock Common Stock 228336 D Series B Preferred Stock Common Stock 79998 D The Series Seed Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC is the ultimate general partner of PIF II. The Series A Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration, at any time at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date. /s/ Partners Innovation Fund II, L.P. By: Julius Knowles, Authorized Signatory 2020-06-25